Thulium170QualityChecker

Utility description: Thulium-170

Thulium-170 Quality Checker — Thulium-170 for Synovitis Therapy and Palliative Care

ℹ️  Utility checks critical parameters of Thulium-170:
    • Radionuclidic purity (≥99.5%)
    • Thulium-171 impurity (≤0.1%) — CRITICAL!
    • Ytterbium-175 impurity (≤0.5%)
    • Radiochemical purity (≥95%)
    • Free thulium (≤5%)
    • pH, endotoxins, sterility, heavy metals

⚠️  CRITICAL: Thulium-171 (T½=1.9 years) creates long-term waste issues.
    Tm-170 is mainly used as colloids for synovectomy.

Usage:
  Thulium170QualityChecker.exe                            → demo mode (console output)
  Thulium170QualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Thulium171ImpurityPercent,Ytterbium175ImpurityPercent,RadiochemicalPurityPercent,FreeThuliumPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType

Example (sterility: 0=sterile, 1=contaminated):
  TM170-COL-2026-001,100.0,99.8,0.05,0.1,98.0,2.0,6.5,20.0,0,2,ColloidSynovectomy

Supported product types:
• ColloidSynovectomy — radiosynovectomy
• CitrateSolution — solutions for interstitial therapy

— WHY IS THIS NEEDED?
Thulium-170 (T½=128.6 days) is a beta-emitter with soft energy (E_max=0.968 MeV):
• Ideal for radiosynovectomy (treatment of synovial membrane inflammation) due to short beta-particle range in tissues (~1-2 mm)
• Also used as citrate or other complexes for palliative therapy or interstitial administration
• Produced by neutron irradiation of enriched Yb-169 or Yb-170 followed by decay to Tm-170 (or direct Tm irradiation)

⚠️  CRITICAL:
• Radionuclidic purity ≥99.5% — presence of other isotopes is unacceptable.
• Thulium-171 (T½=1.92 years) impurity ≤0.1% — CRITICAL PARAMETER. Long-lived isotope that makes radioactive waste hazardous for many years. Even trace amounts are strictly regulated.
• Ytterbium-175 (T½=4.18 days) impurity ≤0.5% — Parent isotope. If not removed or cooling time not observed, it increases patient radiation dose without therapeutic benefit.
• Radiochemical purity ≥95% — For synovectomy, thulium must be in the form of a stable colloid with specific particle size. For other applications — in the form of a soluble complex (citrate).
• Free thulium ≤5% — Ionic thulium accumulates in bones (as a lanthanide), which is undesirable in local joint therapy.
• pH 4.0–7.5, Endotoxins ≤175 EU/vial, Sterility — standard safety requirements.
• Heavy metals ≤10 ppm — Precursor purity control.

Key features:
• Strict control of long-lived Tm-171 impurity
• Assessment of suitability for local therapy (synovectomy)
• Control of free thulium content

Critical parameters:
• Radionuclidic purity: ≥99.5%
• Tm-171 impurity: ≤0.1% (CRITICAL!)
• Yb-175 impurity: ≤0.5%
• Radiochemical purity: ≥95.0%
• Free thulium: ≤5.0%
• Heavy metals: ≤10 ppm
• pH: 4.0–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth

💡 Usage tips:
1. Production of Tm-170 often involves separation from ytterbium target. Separation quality determines Yb and Tm-171 impurity levels.
2. For synovectomy, colloid particle size must be strictly controlled (similar to P-32 or Y-90) to avoid leakage to lymph nodes.
3. Half-life of 128 days is convenient for logistics, but decay correction is required for dose calculation.
4. Tm-170 also emits low-energy gamma quanta (84 keV), allowing imaging of drug distribution.

⚠️ Note: Thulium-170 is an alternative to Y-90 and P-32 for synovectomy of small joints (hand, foot) due to softer beta energy, reducing risk of damage to surrounding healthy tissues. However, the problem of long-lived Tm-171 impurity is the main limitation for its widespread adoption.